Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

To Treat or Not to Treat Metastatic Cancer Patients with Poor Performance Status: a Prospective Experience.

Kullmann T, Gauthier H, Serrate C, Pouessel D, le Maignan C, Misset JL, Culine S.

Pathol Oncol Res. 2017 Jan;23(1):139-144. doi: 10.1007/s12253-016-0111-4. Epub 2016 Sep 7.

PMID:
27605003
2.

[Management of metastatic bladder cancer].

Gauthier H, Serrate C, Pouessel D, Le Maignan C, Teixeira L, Culine S.

Rev Prat. 2014 Dec;64(10):1405-7. French.

PMID:
25668832
3.

Very fast recovery of acute disseminated intravascular coagulation with abiraterone acetate in a patient with bone metastases from castrate-resistant prostate cancer.

Gauthier H, Serrate C, Pouessel D, leMaignan C, Teixeira L, Culine S.

Case Rep Oncol. 2014 Sep 5;7(3):625-7. doi: 10.1159/000367781. eCollection 2014 Sep.

4.

Dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy in bladder cancer: ready for prime time?

Pouessel D, Gauthier H, Serrate C, Pfister C, Culine S.

J Clin Oncol. 2014 Dec 20;32(36):4168-9. doi: 10.1200/JCO.2014.58.0498. Epub 2014 Nov 10. No abstract available.

PMID:
25385728
5.

[Chemotherapy in castrate-resistant metastatic prostate cancer].

Pouessel D, Serrate C, Gauthier H, Hennequin C, Culine S.

Rev Prat. 2013 Apr;63(4):511-4. French.

PMID:
23682481
6.

Imaging response in neuroendocrine tumors treated with targeted therapies: the experience of sunitinib.

Faivre S, Ronot M, Dreyer C, Serrate C, Hentic O, Bouattour M, Bruno O, Couvelard A, Vilgrain V, Raymond E.

Target Oncol. 2012 Jun;7(2):127-33. doi: 10.1007/s11523-012-0216-y. Epub 2012 May 15.

PMID:
22585430
7.

[MET: new target, new combinations].

Serrate C, Watson S, Vignot S.

Bull Cancer. 2011 Jun;98(6):689-96. doi: 10.1684/bdc.2011.1376. Review. French.

8.

Changes in tumor density in patients with advanced hepatocellular carcinoma treated with sunitinib.

Faivre S, Zappa M, Vilgrain V, Boucher E, Douillard JY, Lim HY, Kim JS, Im SA, Kang YK, Bouattour M, Dokmak S, Dreyer C, Sablin MP, Serrate C, Cheng AL, Lanzalone S, Lin X, Lechuga MJ, Raymond E.

Clin Cancer Res. 2011 Jul 1;17(13):4504-12. doi: 10.1158/1078-0432.CCR-10-1708. Epub 2011 Apr 29.

9.

[Sonic Hedgehog signaling pathway: from embryology to molecular targeted therapies].

Watson S, Serrate C, Vignot S.

Bull Cancer. 2010 Dec;97(12):1477-83. doi: 10.1684/bdc.2010.1231. Review. French.

10.

Diethylstilbestrol (DES) retains activity and is a reasonable option in patients previously treated with docetaxel for castration-resistant prostate cancer.

Serrate C, Loriot Y, De La Motte Rouge T, Gross-Goupil M, Massard C, Escudier B, Bossi A, Fizazi K.

Ann Oncol. 2009 May;20(5):965. doi: 10.1093/annonc/mdp112. No abstract available.

PMID:
19403938
11.

Epstein-Barr virus-associated lymphoproliferation awareness in hemophagocytic syndrome complicating thiopurine treatment for Crohn's disease.

Serrate C, Silva-Moreno M, Dartigues P, Poujol-Robert A, Sokol H, Gorin NC, Coppo P.

Inflamm Bowel Dis. 2009 Oct;15(10):1449-51. doi: 10.1002/ibd.20823. No abstract available.

PMID:
19177429

Supplemental Content

Loading ...
Support Center